A detailed history of Jefferies Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Jefferies Group LLC holds 81,237 shares of JNJ stock, worth $11.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
81,237
Previous 17,837 355.44%
Holding current value
$11.9 Million
Previous $3.17 Million 319.14%
% of portfolio
0.13%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

BUY
$161.33 - $179.52 $10.2 Million - $11.4 Million
63,400 Added 355.44%
81,237 $13.3 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $9.85 Million - $11 Million
61,032 Added 302.06%
81,237 $13.3 Million
Q2 2022

Sep 21, 2023

BUY
$168.19 - $186.01 $1.26 Million - $1.4 Million
7,510 Added 72.72%
17,837 $3.17 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $1.66 Million - $1.84 Million
9,878 Added 95.65%
20,205 $3.18 Million
Q1 2022

Sep 21, 2023

SELL
$158.14 - $179.59 $18.5 Million - $21 Million
-116,828 Reduced 91.88%
10,327 $1.83 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $18.5 Million - $21 Million
-116,828 Reduced 91.88%
10,327 $1.83 Million
Q4 2021

Sep 21, 2023

SELL
$155.93 - $173.01 $1.1 Million - $1.22 Million
-7,052 Reduced 5.25%
127,155 $21.8 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $1.1 Million - $1.22 Million
-7,052 Reduced 5.25%
127,155 $21.8 Million
Q3 2021

Sep 21, 2023

SELL
$161.5 - $179.47 $3.37 Million - $3.74 Million
-20,857 Reduced 13.45%
134,207 $21.7 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $3.37 Million - $3.74 Million
-20,857 Reduced 13.45%
134,207 $21.7 Million
Q2 2021

Sep 21, 2023

BUY
$159.48 - $171.07 $8.61 Million - $9.24 Million
53,990 Added 53.42%
155,064 $25.5 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $8.61 Million - $9.24 Million
53,990 Added 53.42%
155,064 $25.5 Million
Q1 2021

Sep 21, 2023

SELL
$153.07 - $170.48 $9.6 Million - $10.7 Million
-62,730 Reduced 38.3%
101,074 $16.6 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $9.6 Million - $10.7 Million
-62,730 Reduced 38.3%
101,074 $16.6 Million
Q4 2020

Sep 21, 2023

BUY
$137.11 - $157.38 $11.3 Million - $13 Million
82,567 Added 101.64%
163,804 $25.8 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $18.8 Million - $21.6 Million
136,965 Added 510.32%
163,804 $25.8 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $13.8 Million - $15.1 Million
-98,129 Reduced 78.52%
26,839 $4 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $7.69 Million - $9.28 Million
59,705 Added 91.48%
124,968 $17.6 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $1.25 Million - $1.73 Million
11,204 Added 20.73%
65,263 $8.56 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $5.64 Million - $6.48 Million
44,225 Added 449.72%
54,059 $7.89 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $6.46 Million - $7.24 Million
-50,901 Reduced 83.81%
9,834 $1.27 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $5.9 Million - $6.49 Million
45,017 Added 286.4%
60,735 $8.46 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $4.28 Million - $4.76 Million
-34,048 Reduced 68.42%
15,718 $2.2 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $7,370 - $8,870
60 Added 0.12%
49,766 $6.42 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2.7 Million - $3.18 Million
22,231 Added 80.91%
49,706 $6.87 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $487,032 - $537,449
-4,079 Reduced 12.93%
27,475 $3.33 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $1.21 Million - $1.44 Million
-9,708 Reduced 23.53%
31,554 $4.04 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $16.3 Million - $17.8 Million
-123,916 Reduced 75.02%
41,262 $5.77 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $21.4 Million - $22.4 Million
165,178
165,178 $21.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.